Stereotactic Interstitial Brachytherapy of Malignant Astrocytomas with Remarks on Postimplantation Computed Tomographic Appearance
- 1 September 1988
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurosurgery
- Vol. 23 (3), 348-354
- https://doi.org/10.1227/00006123-198809000-00011
Abstract
Seventeen patients were treated with stereotactically implanted high activity iodine-125 seeds, 12 patients for recurrent malignant astrocytomas (Protocol I) and 5 patients for newly diagnosed glioblastomas (Protocol II). Total radiation dosage to the recurrent tumors in Protocol I, increasing prior external beam irradiation, averaged 13,500 cGy. In the follow-up period of 6 to 50 months, the survival rate was 93% at 6 months, 60% at 12 months, 50% at 18 months, and 38% at 24 months after implantation. In Protocol II, brachytherapy was used as an interstitial radiation boost to the conventional treatment of newly diagnosed glioblastomas. External beam therapy and interstitial brachytherapy provided 11,000 cGy to these tumors. In the follow-up period of 15 to 27 months, there was a 100% survival at 12 months, 75% at 18 months, and 25% at 24 months after implantation. Eight of our 17 patients required reoperation for persistent or recurrent mass lesions at 6 to 15 months postimplantation; 7 were found to harbor masses of radionecrosis containing nests of anaplastic astrocytes; 1 had frank tumor recurrence. Median survival in this group of patients requiring reoperation was 18.7 months postimplantation. In a review of postimplantation computed tomographic scans, significant mass effect and crossover of hypodensity or enhancement into the corpus callosum or opposite hemisphere were found to have prognostic significance; persistent areas of contrast enhancement and excessive peritumoral hypodensity did not.This publication has 9 references indexed in Scilit:
- Improved precision of interstitial brain tumor irradiation using the brw ct stereotaxic guidance systemInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Normal brain iodine-125 radiation damage: effect of dose and irradiated volume in a canine model.Radiology, 1986
- Technique and preliminary results of interstitial irradiation for primary brain tumorsJournal of Neuro-Oncology, 1986
- Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implicationsCancer, 1985
- Transient early computed tomographic changes mimicking tumor progression after brain tumor irradiation.Radiology, 1982
- Studies with encapsulated 125I sources. II. determination of the relative biological effectiveness using cultured mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Interstitial brachytherapy of primary brain tumorsJournal of Neurosurgery, 1980
- Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomasJournal of Neurosurgery, 1978
- Delayed radiation necrosis of the brainJournal of Neurosurgery, 1977